![Robert M. Stephan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert M. Stephan
General Counsel bei
US Securities & Exchange Commission
Profil
Robert M.
Stephan is currently the General Counsel at the US Securities & Exchange Commission.
He previously worked as an Independent Director at Cornerstone Therapeutics, Inc., Director at National Association of Corporate Treasurers, Secretary, Director & Vice President at Chiesi Pharmaceuticals, Inc., Secretary, Vice President & General Counsel at Cerestar USA, Inc., Vice President & Group General Counsel at General Mills, Inc., Vice President & Associate General Counsel at United States Surgical Corp., Principal at Wang Laboratories, Inc., Vice President-Business Development at The 41st Parameter, Inc., Secretary, Vice President & General Counsel at Montedison SpA, Principal at SmartForce Plc, Principal at Apple Communications, Inc., Principal at NETg, Inc., and Principal at KnowledgeNet, Inc. He received his undergraduate degree from Lawrence University and his graduate degree from the University of Wisconsin.
Aktive Positionen von Robert M. Stephan
| Unternehmen | Position | Beginn |
|---|---|---|
US Securities & Exchange Commission
 US Securities & Exchange Commission Investment Banks/BrokersFinance Provides securities and commission services | General Counsel | 06.05.2010 |
Ehemalige bekannte Positionen von Robert M. Stephan
| Unternehmen | Position | Ende |
|---|---|---|
| CORNERSTONE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.02.2014 |
Chiesi Pharmaceuticals, Inc.
 Chiesi Pharmaceuticals, Inc. Aerospace & DefenseElectronic Technology Founded in 2006, Chiesi Pharmaceuticals, Inc. specializes in innovative therapeutic solutions primarily in respiratory health, rare and ultra-rare diseases, neonatology, and specialized care. The private company is based in Rockville, MD. The company operates over 30 commercial subsidiaries and maintains a strong research and development presence through its Parma research center and six other international hubs. Chiesi emphasizes patient-centered care, clinical trial transparency, and supply chain sustainability, engaging suppliers in responsible practices. Its innovation pipeline includes small molecules, biologics, and advanced therapies such as cell therapies, aiming to address unmet medical needs and improve quality of life. | Unternehmenssekretär | 01.01.2012 |
National Association of Corporate Treasurers
 National Association of Corporate Treasurers Miscellaneous Commercial ServicesCommercial Services Operates as a professional association of treasurers | Direktor/Vorstandsmitglied | - |
Cerestar USA, Inc.
 Cerestar USA, Inc. Food: Major DiversifiedConsumer Non-Durables Corn sweeteners, industrial starches | General Counsel | - |
Montedison SpA
 Montedison SpA Food: Specialty/CandyConsumer Non-Durables Invests in animal feed, sugar and oils, chemicals, energy, insurance, engineering and shipbuilding businesses | General Counsel | - |
Ausbildung von Robert M. Stephan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Cerestar USA, Inc.
Cerestar USA, Inc. Food: Major DiversifiedConsumer Non-Durables Corn sweeteners, industrial starches | Consumer Non-Durables |
General Mills, Inc.
 General Mills, Inc. Food: Major DiversifiedConsumer Non-Durables Manufactures and markets consumer & pet food products | Consumer Non-Durables |
United States Surgical Corp.
 United States Surgical Corp. Medical SpecialtiesHealth Technology Manufactures wound closure products and surgical devices | Health Technology |
Wang Laboratories, Inc.
 Wang Laboratories, Inc. Information Technology ServicesTechnology Services Develops, markets, and supports software and provides integration and support services for computers | Technology Services |
The 41st Parameter, Inc.
 The 41st Parameter, Inc. Information Technology ServicesTechnology Services Provides internet fraud detection and prevention solutions | Technology Services |
Montedison SpA
Montedison SpA Food: Specialty/CandyConsumer Non-Durables Invests in animal feed, sugar and oils, chemicals, energy, insurance, engineering and shipbuilding businesses | Consumer Non-Durables |
SmartForce Plc
 SmartForce Plc Information Technology ServicesTechnology Services Provides eLearning content and technology products | Technology Services |
Apple Communications, Inc.
 Apple Communications, Inc. Wireless TelecommunicationsCommunications Provides radio telephone communication services | Communications |
NETg, Inc.
 NETg, Inc. Internet Software/ServicesTechnology Services Provides integrated corporate learning solutions | Technology Services |
KnowledgeNet, Inc.
 KnowledgeNet, Inc. Packaged SoftwareTechnology Services Develops teaching software | Technology Services |
Lawrence University
 Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Securities & Exchange Commission
US Securities & Exchange Commission Investment Banks/BrokersFinance Provides securities and commission services | Finance |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
National Association of Corporate Treasurers
National Association of Corporate Treasurers Miscellaneous Commercial ServicesCommercial Services Operates as a professional association of treasurers | Commercial Services |
Chiesi Pharmaceuticals, Inc.
Chiesi Pharmaceuticals, Inc. Aerospace & DefenseElectronic Technology Founded in 2006, Chiesi Pharmaceuticals, Inc. specializes in innovative therapeutic solutions primarily in respiratory health, rare and ultra-rare diseases, neonatology, and specialized care. The private company is based in Rockville, MD. The company operates over 30 commercial subsidiaries and maintains a strong research and development presence through its Parma research center and six other international hubs. Chiesi emphasizes patient-centered care, clinical trial transparency, and supply chain sustainability, engaging suppliers in responsible practices. Its innovation pipeline includes small molecules, biologics, and advanced therapies such as cell therapies, aiming to address unmet medical needs and improve quality of life. | Electronic Technology |
Wählen Sie MarketScreener 
